4D Molecular Therapeutics Inc
(FDMT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 78,569 | 52,351 | 108,298 | 113,484 | 75,970 |
| Marketable Securities | 121,885 | 161,203 | 119,417 | 127,604 | 160,183 |
| TOTAL | $207,040 | $220,511 | $232,478 | $246,523 | $243,047 |
| Non-Current Assets | |||||
| PPE Net | 21,614 | 22,262 | 22,052 | 21,097 | 18,456 |
| Investments And Advances | 1,405 | 4,908 | 11,122 | 20,532 | 48,362 |
| Other Non-Current Assets | 13,962 | 14,165 | 14,512 | 14,784 | 15,061 |
| TOTAL | $36,981 | $41,335 | $47,686 | $56,413 | $81,879 |
| Total Assets | $244,021 | $261,846 | $280,164 | $302,936 | $324,926 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,408 | 3,322 | 1,480 | 3,316 | 2,681 |
| Accrued Expenses | 5,414 | 8,870 | 7,244 | 6,163 | 5,264 |
| TOTAL | $11,278 | $15,731 | $13,564 | $14,331 | $12,091 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 778 | 884 | 2,207 | 2,256 | 2,109 |
| Other Non-Current Liabilities | 13,253 | 13,702 | 14,155 | 14,636 | 15,018 |
| TOTAL | $14,137 | $14,778 | $15,156 | $16,088 | $16,779 |
| Total Liabilities | $25,415 | $30,509 | $28,720 | $30,419 | $28,870 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,260 | 33,234 | 32,392 | 32,382 | 32,300 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | -343,172 | -314,490 | -287,111 | -261,420 | -233,334 |
| Other shareholders' equity | -270 | -1,196 | -1,851 | -1,827 | -1,421 |
| TOTAL | $218,606 | $231,337 | $251,444 | $272,517 | $296,056 |
| Total Liabilities And Equity | $244,021 | $261,846 | $280,164 | $302,936 | $324,926 |